The Effects of Aromatherapy on the Incidence and Severity of Acute Pain
NCT ID: NCT03122574
Last Updated: 2017-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2015-11-30
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Distraction to Reduce Pain and Distress in the Pediatric Emergency Department
NCT02326623
Active vs Passive Distraction on Procedural Pain in the Pediatric Emergency Department
NCT01960166
Effectiveness of a Pain Assessment and Management Program for Respite Workers Supporting Children With Disabilities
NCT03421795
A Distraction Protocol for Peripheral Intravenous (IV) Placement in the Pediatric Emergency Department
NCT00924417
Painful Procedures in the Emergency Department: A Distraction Intervention
NCT00338364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Pure (100%) lavender aromatherapy
Lavender Aromatherapy
100% pure lavender aromatherapy was administered using person essential oil diffusor sachets, consisting of three drops of oil on a surgical sponge covered in a sealed plastic packet.
Placebo Control
Pure (100%) jojoba aromatherapy
Jojoba Aromatherapy
100% pure jojoba aromatherapy was administered using person essential oil diffusor sachets, consisting of three drops of oil on a surgical sponge covered in a sealed plastic packet. This colorless, odorless oil was used as a placebo comparator.
Standard of care Control
No aromatherapy control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lavender Aromatherapy
100% pure lavender aromatherapy was administered using person essential oil diffusor sachets, consisting of three drops of oil on a surgical sponge covered in a sealed plastic packet.
Jojoba Aromatherapy
100% pure jojoba aromatherapy was administered using person essential oil diffusor sachets, consisting of three drops of oil on a surgical sponge covered in a sealed plastic packet. This colorless, odorless oil was used as a placebo comparator.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking
* Parental written consent
* Child's verbal assent
Exclusion Criteria
* Peanut allergy (nut oils processed by manufacturer)
* Medical hypersensitivity to smell
* Asthma triggered by foreign scent
* Frequent venipuncture (5 or more a year)
* Current pain or anxiety medication
7 Years
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American University
OTHER
Children's National Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katherine Curtin
Clinical Research Coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katherine B Curtin, MA
Role: PRINCIPAL_INVESTIGATOR
Children's National Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's National Health System
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro0006362
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.